We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RF icon
276
Regions Financial
RF
$26.9B
$70K 0.01%
6,057
+1,269
+27% +$14.2K
GSAT icon
277
Globalstar
GSAT
$10.8B
$69K 0.01%
15,015
+8,348
+125% +$43K
DMYT.WS
278
DELISTED
dMY Technology Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Clas
DMYT.WS
$69K 0.01%
+23,000
New +$51.5K
KPLTW
279
DELISTED
Katapult Holdings Warrant
KPLTW
$68K 0.01%
68,196
-22,522
-25% -$25.8K
IBB icon
280
PUT
iShares Biotechnology ETF
IBB
$9.81B
$67K 0.01%
+20,500
New +$2.78M
DISH
281
PUT
DELISTED
DISH Network Corp.
DISH
$67K 0.01%
35,000
+15,000
+75% +$495K
MRTX
282
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$66K 0.01%
15,400
+8,500
+123% +$1.16M
BAC icon
283
CALL
Bank of America
BAC
$448B
$65K 0.01%
+40,000
New +$996K
PFNX
284
DELISTED
Pfenex Inc.
PFNX
$64K 0.01%
+5,000
New +$52.9K
KYNB
285
Kyntra Bio
KYNB
$28.6M
$63K 0.01%
+61
New +$65.6K
ORSNR
286
DELISTED
Orisun Acquisition Corp. Right
ORSNR
$63K 0.01%
105,000
-102,850
-49% -$43.2K
TLRY icon
287
CALL
Tilray
TLRY
$651M
$62K 0.01%
41,160
-20,420
-33% -$1.36M
SNDX icon
288
PUT
Syndax Pharmaceuticals
SNDX
$1.81B
$61K 0.01%
20,200
-24,800
-55% -$378K
AR icon
289
CALL
Antero Resources
AR
$11.6B
$60K 0.01%
+300,000
New +$950K
TOL icon
290
CALL
Toll Brothers
TOL
$14.3B
$60K 0.01%
+115,200
New +$4.66M
VAR
291
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
$59K 0.01%
+78,500
New +$12.3M
ABUS icon
292
PUT
Arbutus Biopharma
ABUS
$923M
$58K 0.01%
+25,000
New +$76K
ACAD icon
293
Acadia Pharmaceuticals
ACAD
$5.07B
$58K 0.01%
+1,417
New +$61.2K
DFNS.WS
294
DELISTED
LGL Systems Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for shares of Clas
DFNS.WS
$58K 0.01%
53,661
-290,378
-84% -$311K
SCPE.WS
295
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$58K 0.01%
50,000
-151,453
-75% -$162K
PCPL.WS
296
DELISTED
CC Neuberger Principal Holdings I Warrants, each whole warrant exercisable for one Class A ordinary
PCPL.WS
$56K 0.01%
+30,949
New +$48.8K
INVA icon
297
CALL
Innoviva
INVA
$1.5B
$53K 0.01%
234,100
-801,800
-77% -$10.2M
ACAD icon
298
PUT
Acadia Pharmaceuticals
ACAD
$5.07B
$51K 0.01%
+20,800
New +$898K
BAC icon
299
Bank of America
BAC
$448B
$51K 0.01%
2,113
-18,629
-90% -$464K
SGRY icon
300
CALL
Surgery Partners
SGRY
$1.96B
$51K 0.01%
+25,000
New +$444K
10 11
12
13 14

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.